Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BMPR1B | O00238 | 1/20 | 0.31 |
| ▸ | ACVRL1 | P37023 | 1/20 | 0.31 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25975507 | 0.95 | KDM4E (0.32) | BMPR1BACVRL1ACVR1KDM4EATM | |
| SCHEMBL26415830 | 0.94 | PTGER4 (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL26415840 | 0.94 | HCRTR1 (0.33) | BMPR1BACVRL1ACVR1KDM4EATM | |
| SCHEMBL26416793 | 0.92 | PDE6D (0.31) | BMPR1BACVRL1ACVR1KDM4EATM | |
| SCHEMBL21863023 | 0.91 | PTGER4 (0.31) | KDM4EATML3MBTL1 | |
| SCHEMBL25605973 | 0.91 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL26415822 | 0.91 | PTGER4 (0.31) | KDM4EATML3MBTL1 | |
| SCHEMBL24152428 | 0.91 | KDM4E (0.34) | BMPR1BACVRL1ACVR1KDM4EATM | |
| SCHEMBL22826601 | 0.90 | PTGER4 (0.33) | — | |
| SCHEMBL26416005 | 0.90 | KDM4E (0.31) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | CRY1, ORC3, ODC1 | BMPR1B 872/4885ACVRL1 461/4885ACVR1 989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.